highly significantp = 0.032
In patients presenting early (<3 hours time-to-reperfusion), compared to placebo there was a highly significant reduction after 4 months both in necrotic core zone (0.3% vs. 2.4%, p = 0.032) and in total infarct size (8.0% vs. 16.0%; p = 0.032), suggesting a longer-term treatment effect in these patients.